In a previous report (Woolfrey et al., J. Clin. Microbiol. 13:58-61, 1981) Microorganisms. The isolates of Enterobacteriaceae were selected from the stock culture collection of the 1,013 isolates which were used in our previous evaluation of the Repliscan system (3). The selected isolates included 146 Escherichia spp., 43 Shigella spp., 42 Salmonella spp., 28 Citrobacter spp., 88 Enterobacter spp., 144 Klebsiella spp., 94 Serratia spp., and 107 Proteus spp. To avoid excessive testing, we used fewer Escherichia spp. than we had used in our previous investigation by randomly selecting a smaller but statistically significant number of isolates from the Escherichia spp. stock cultures. Providencia spp. were not evaluated because too few isolates were available in the stock culture collection. For the other genera, all isolates which could be retrieved from the stock collection were selected. Isolates were retrieved from stock cultures by streaking on MacConkey agar and incubating at 35°C in air for 18 to 24 h. These cultures served as the common growth sources for inoculation in the Repliscan II and API 20E tests.
Our previously reported evaluation of the Repliscan system (3) indicated that it was unreliable and extremely limited in its ability to identify Enterobacteriaceae. Recent improvements in media, data base, and hardware of Repliscan prompted us to evaluate the improved system (Repliscan II; Cathra International, Inc., St. Paul, Minn.).
MATERIALS AND METHODS
Experimental design. This study was designed to evaluate the accuracy of the Repliscan II system for identification of Enterobacteriaceae. Parallel identifications of 692 isolates of Enterobacteriaceae which were used in our previous evaluation of the Repliscan system were performed with API 20E (Analytab Products, Plainview, N.Y.) and Repliscan II (3) . Each isolate was identified to the species level by both methods, and discrepancies were refereed by classical microbiological methods (2) .
Microorganisms. The isolates of Enterobacteriaceae were selected from the stock culture collection of the 1,013 isolates which were used in our previous evaluation of the Repliscan system (3). The selected isolates included 146 Escherichia spp., 43 Shigella spp., 42 Salmonella spp., 28 Citrobacter spp., 88 Enterobacter spp., 144 Klebsiella spp., 94 Serratia spp., and 107 Proteus spp. To avoid excessive testing, we used fewer Escherichia spp. than we had used in our previous investigation by randomly selecting a smaller but statistically significant number of isolates from the Escherichia spp. stock cultures. Providencia spp. were not evaluated because too few isolates were available in the stock culture collection. For the other genera, all isolates which could be retrieved from the stock collection were selected. Isolates were retrieved from stock cultures by streaking on MacConkey agar and incubating at 35°C in air for 18 to 24 h. These cultures served as the common growth sources for inoculation in the Repliscan II and API 20E tests.
Repliscan II system. The principles of design and use of the Repliscan system have been described in our previous report (3) . Repliscan II is a modification of Repliscan involving changes in medium composition, additions to and refinements of the data base, software and hardware modifications, and the use of a floating inoculating pin replicator head. Inoculum suspensions, prepared by transferring single colonies from MacConkey agar to 5 ml of tryptic soy broth and incubating them in air at 35°C for 2 to 3.5 h, were visually adjusted to the density range of 0.5 to 1.0 McFarland standards. Approximately 0.5 ml of each suspension was placed into the wells of the inoculating apparatus. Inoculations of the identification batteries (Repliplates) were performed within 0.5 h after standardization of the inoculum suspensions by using 1-mm floating pins in the replicator device. After absorption of the inocula into the media, the Repliplates were inverted and incubated for 16 to 18 h in air at 35°C. After incubation, the Repliplates were interpreted in accordance with the instructions for using the Repliscan II system. Supplemental testing, when indicated for complete identification, was performed (1), we found the initial Repliscan system to be unsatisfactory for identifying the Enterobacteriaceae most frequently encountered in clinical microbiology laboratories. Since then, the initial Repliscan system has undergone considerable alteration of hardware, software, and medium formulation. These changes prompted us to evaluate the updated version, Repliscan II, by using the same bacterial isolates and experimental design which we used in our previous study. The results of the present study indicate that Repliscan II acceptably identifies the Enterobacteriaceae commonly encountered in clinical microbiology laboratories and that it is a significant improvement over the previous Repliscan system. Fewer than 1% of all isolates were classified as unknown, a significant improvement over the 22% which had previously been classified as such. Of particular importance is the finding that Repliscan II satisfactorily identifies the Salmonella and Shigella genera, since both were completely misidentified by the previous system. The identification of Citrobacter and Enterobacter spp. presents the greatest challenge to the system; correct species identifications were 82 and 85%, respectively.
The 16 identification tests used by the Repliscan II system are the same as those used in the previous Repliscan system. However, improvement and standardization of the Repliplate media seems to have eliminated many of the problems related to reaction and interpretation. Software for the system has been improved so that a list of suggested additional tests for identifi- In summary, the Repliscan II system was found to be a significant improvement over the initial Repliscan system. Acceptable identification of Enterobacteriaceae commonly encountered in clinical microbiology laboratories is now provided. Repliscan II appears to be a potentially useful and cost-effective instrument for large-volume laboratories.
